Judge Rules For Andrx In Bristol-Myers Patent Suit Over Monopril
By Marius Meland · June 7, 2004, 12:00 AM EDT
Andrx Corp. does not infringe a patent that Bristol-Myers Squibb Co. holds for its Monopril hypertension drug, a federal judge has ruled in a decision that clears the way for Andrx...
To view the full article, register now.
Try a seven day FREE Trial
Already a subscriber? Click here to login